Skip to content

Clinical and Histological Evaluation of Healos® for Alveolar Ridge Augmentation

Clinical and Histological Evaluation of Healos® for Alveolar Ridge Augmentation

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01154868
Enrollment
0
Registered
2010-07-01
Start date
2010-08-31
Completion date
2011-02-28
Last updated
2015-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implantation

Brief summary

The purpose of this study is to document and evaluate how a bone graft material (Healos®) can help rebuild bone width. Dental implants can only be placed when enough bone is found and this bone graft may help to rebuild bone width for dental implant placement. The ultimate goal of this study is to evaluate how this graft material can help bone healing.

Interventions

PROCEDUREAlveolar ridge augmentation

Under local anesthesia, full-thickness mucoperiosteal flaps will be elevated, followed by degranulation, and collection of all clinical measurements. Crestal and vertical releasing cuts will be performed using diamond-coated discs on the edentulous ridge in need of augmentation. A sequence of bone chisels and osteotomes will be used to split the alveolar ridge in half until a desirable width for implant placement is achieved. Healos® will then be inserted between both osseous plates. Fixation screws will be used as needed to stabilize the expanded alveolar ridge. Collagen barrier membranes (Ossix Plus) will be used to cover the osseous wound. Flaps will be approximated to achieve primary wound closure.

Sponsors

Johnson & Johnson
CollaboratorINDUSTRY
William Giannobile
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* age 21 and older * 2-4 ADJACENT maxillary front teeth missing * require ridge augmentation and dental implant * nonsmoker for at least 6 months * willing to follow oral hygiene instruction and other study instruction * able to read, understand and sign informed consent

Exclusion criteria

* Residual upper jaw bone equal to or narrower than 3mm. * Insufficient gum tissue to obtain wound closure after surgery. * Clinically significant or unstable (as defined by the investigators) systemic diseases affecting bone or soft tissue growth; or other kidney, liver, heart, thyroid, blood, autoimmune or acute infectious diseases that makes interpretation of the data more difficult * A history of head & neck radiation treatment due to certain medical conditions. * Taking steroids, tetracycline or tetracycline analogs, bone therapeutic levels of fluorides, bisphosphonates, medications affecting bone turnover, antibiotics for \>7 days or any investigational drug * Pregnancy or become pregnant during the length of the study * Wearing removable partial dentures that may put pressure over the area where the bone graft will be placed.

Design outcomes

Primary

MeasureTime frame
horizontal (width) bone gain or loss in millimeters.18 weeks

Secondary

MeasureTime frame
radiographic bone changes measured using computer tomography18 weeks
percentage of new bone formation in the alveolar bone core biopsies.18 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026